[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Zabner et al., 1997 - Google Patents

Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo.

Zabner et al., 1997

View PDF
Document ID
16196121491556529667
Author
Zabner J
Cheng S
Meeker D
Launspach J
Balfour R
Perricone M
Morris J
Marshall J
Fasbender A
Smith A
Welsh M
et al.
Publication year
Publication venue
The Journal of clinical investigation

External Links

Snippet

Cationic lipids show promise as vectors for transfer of CFTR cDNA to airway epithelia of patients with cystic fibrosis (CF). However, previous studies have not compared the effect of DNA-lipid to DNA alone. Recently, we developed a formulation of plasmid encoding CFTR …
Continue reading at www.jci.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors

Similar Documents

Publication Publication Date Title
Zabner et al. Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo.
Moretti et al. Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy
Zabner et al. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis
Guzman et al. Efficient and selective adenovirus-mediated gene transfer into vascular neointima.
Goldman et al. Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study
JP2948910B2 (en) Adenovirus vectors for gene therapy
Ferrari et al. Polyethylenimine shows properties of interest for cystic fibrosis gene therapy
Kukowska-Latallo et al. Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector
EP0759694B1 (en) Method for in vivo delivery of therapeutic agents via liposomes
Griesenbach et al. Comparison between intratracheal and intravenous administration of liposome–DNA complexes for cystic fibrosis lung gene therapy
Lai et al. Correction of renal tubular acidosis in carbonic anhydrase II-deficient mice with gene therapy.
Feldman et al. Improved efficiency of arterial gene transfer by use of poloxamer 407 as a vehicle for adenoviral vectors
JP2018007673A (en) Expression vectors containing hybrid ubiquitin promoters
US20230338411A1 (en) Compositions and methods for targeted delivery to cells
WO1994028938A9 (en) Adenovirus vectors for gene therapy sponsorship
JP2010070565A (en) Composition and method for enhancing delivery of therapeutic agent to cell
Muller et al. Catheter-mediated pulmonary vascular gene transfer and expression.
Sinn et al. Viscoelastic gel formulations enhance airway epithelial gene transfer with viral vectors
US5962429A (en) Complexes of adenovirus with cationic molecules
US20060228407A1 (en) Enhanced delivery via serpin enzyme complex receptor
Ziady et al. Non-viral gene transfer therapy for cystic fibrosis
Sawa et al. Intraluminal water increases expression of plasmid DNA in rat lung
JP4885861B2 (en) Methods for inhibiting cell death or inflammation in mammals
AU737129B2 (en) Long-term expression of gene products by transforming muscle cells
WO2004074482A1 (en) Diabetes and obesity diagnosis method